Zacks Investment Research on MSN

Novocure's Optune Lua gets Japan reimbursement for NSCLC treatment

Novocure NVCR recently announced that Japan’s Ministry of Health, Labour and Welfare has approved reimbursement for Optune Lua through the country’s National Health Insurance program. In Japan, Optune ...
Electronic Design

Running Embedded Lua On Microcontrollers

Very often while developing complex systems, engineers have to greatly simplify the task of writing final user space applications. In this case it is desirable to move as far as possible from the ...
TechRepublic

Lua moves into top 20 of March’s TIOBE Index, Python retains top spot

Lua moves into top 20 of March’s TIOBE Index, Python retains top spot Your email has been sent The release of March’s TIOBE Index of the most popular programming languages saw a few notable changes ...
Business Wire

FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer

The first treatment of its kind for metastatic NSCLC, Optune Lua is approved for use concurrently with PD-1/PD-L1 inhibitors or docetaxel in adult patients with metastatic NSCLC who progressed on or ...